Comparison of Oral Ivermectin and Permethrin 1% Shampoo in the Treatment of Pediculosis Capitis
Objective: To compare the efficacy of Oral Ivermectin with Permethrin 1% Shampoo in the treatment of Pediculosis Capitis
Study Design: Randomized controlled trial
Setting & Study duration: This study was conducted at the Department of Dermatology, Bolan Medical College/ Sandeman Provincial Hospital, Quetta from December 24, 2016 to June 23, 2017 (6 months)
Materials and Methods: All children of either gender having age 5 and above weight more than
15 kg presented with head-lice infestation confirmed by combing the wet hair with a fine-toothed detection comb were enrolled. All patients were randomly allocated into two groups. Patients in group A received oral Ivermectin in dose of 200mcg/kg while patients in group B received application of 1% Permethrin Shampoo. They were called after one week and they received second dose of oral Ivermectin in same dose of 200mcg/kg and application of Permethrin 1% Shampoo and re-evaluated after one week. Treatment was considered effective by absence of live lice by day 15 of treatment.
Data was analyzed in SPSS version 17.Mean age of the patient in the sample was calculated. Male to female ratio was determined in the sample. In both the groups, frequency of patients having no live louse in the head on 15th day was calculated. The frequency in both groups was compared by applying chi square test keeping p-value≤ 0.05.
Results: Majority of the patients presented were females in both group, i.e. 20 (66.7%) and 23 (76.7%) respectively. Insignificant difference was observed in the mean age in between group (p- value 0.482). Efficacy was found significantly higher in oral Ivermectin group 26 (86.7%) as compared to 1% Permethrin Shampoo. (p-value <0.001).
Conclusion: The efficacy of oral Ivermectin group was considerably higher as compared to 1% Permethrin Shampoo in our cohort.
2. Smith CH, Goldman RD. An incurable itch: head lice. Can Fam Physician.
3. Lesshafft H, Baier A, Guerra H, Terashima A, Feldmeier H. Prevalence and risk factors associated with pediculosis capitis in an impoverished urban community in Lima, Peru. J Global infec Dis. 2013;5(4):138.
4. Mohammed A. Head lice infestation in schoolchildren and related factors in
Mafraq governorate, Jordan. Int J Dermatol. 2012;51(2):168-72.
5. Davarpanah MA, Kazerouni AR, Rahmati H, Neirami RN, Bakhtiary H, Sadeghi M. The prevalence of pediculus capitis among the middle schoolchildren in Fars Province, southern Iran. Cas J Int Med.
6. Madke B, Khopkar U. Pediculosis capitis: An update. Ind J Dermatol, Venereol Leprol. 2012;78(4):429.
7. Jahnke C, Bauer E, Hengge UR, Feldmeier H. Accuracy of diagnosis of pediculosis capitis: visual inspection vs wet combing. Arch Dermatol.
8. Gunning K, Pippitt K, Kiraly B, Sayler M, editors. Pediculosis and scabies: a treatment update. Am Fam Physician.2013;86(6):535-41.
9. Tebruegge M, Pantazidou A, Curtis N. What's bugging you? An update on the treatment of head lice infestation. Arc Dis Child Edu Pract Ed.
10. El-Bahnasawy MM, Abdel F, Morsy TA. Human pediculosis: a critical health problem and what about nursing policy? J Egy Soc Parasitol.
11. Burgess IF. Head lice.BMJ Clin Evid. 2011;2011:1703.
12. Cole SW, Lundquist LM. Spinosad for treatment of head lice infestation.
Ann Pharmacother. 2011;45(7-8):954-9.
13. Burgess IF, Brunton ER, Burgess NA. Single application of 4% dimeticone liquid gel versus two applications of 1% permethrin creme rinse for
treatment of head louse infestation: a randomised controlled trial. BMC Dermatol. 2013;13(1):5.
14. Ameen M, Arenas R, Villanueva-Reyes J, Ruiz-Esmenjaud J, Millar D, Domínguez-Dueñas F, et al. Oral ivermectin for treatment of pediculosis capitis.Pediatr Infec D J. 2010;29(11):991-3.
15. Smith CH, Goldman RD. An incurable itch Head lice. Can Fam Physician.
Copyright (c) 2021 Mehvish Afridi, Sara Inayat, Zaib ., Saifullah Kakar, Anila Panezai, Sehrish Ghani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All research articles published in the Journal of Rawalpindi Medical College (JRMC) are fully open access: immediately freely available to read, download, and share. Copyrights of all articles published in JRMC are retained by the authors. First publication rights are granted to JRMC. The journal/publisher is not responsible for subsequent uses of the work.
All articles are published under the Creative Commons Attribution (CC BY-SA 4.0) license.